MRNA · News · 20260731N
Liquidity and Cash Position
Moderna, Inc. · 2026-07-31 · Importance 75 · Surprise 60 · In source text
Moderna improved its expected 2026 year-end cash balance to $4.7 billion-$5.2 billion. The company held $6.91 billion in cash and investments while reporting a $782 million second-quarter GAAP net loss. The higher cash outlook reflects the approximately $200 million reduction in expected 2026 operating expenses.
Key facts
- Moderna improved its expected 2026 year-end cash balance to $4.7 - $5.2 billion. source
- Moderna reported $6.91 billion in cash and investments, described as strong liquidity. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | probable | — | Moderna improved its expected 2026 year-end cash balance to $4.7 - $5.2 billion. |
| cash | positive | realized | — | Moderna reported $6.91 billion in cash and investments, described as strong liquidity. |